CLINICAL_TRIALS
trial_result
· 2021-03-09
Clinical Trial Update: An Open-Label Pilot Study of Sublocade as Treatment for Opiate Use Disorder [Phase 1, Phase 2]
Summary
Open-label pilot study evaluating Sublocade (buprenorphine extended-release) for opioid-use disorder; completed with results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: New York State Psychiatric Institute | Conditions: Opioid-use Disorder | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-03-09